130 related articles for article (PubMed ID: 38364267)
1. Formulation of Carnosic-Acid-Loaded Polymeric Nanoparticles: An Attempt to Endorse the Bioavailability and Anticancer Efficacy of Carnosic Acid against Triple-Negative Breast Cancer.
Chatterjee S; Chakraborty P; Dutta S; Karak S; Mahalanobis S; Ghosh N; Dewanjee S; Sil PC
ACS Appl Bio Mater; 2024 Mar; 7(3):1656-1670. PubMed ID: 38364267
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and evaluation of in vitro cytotoxicity and in vivo antitumor activity of asiatic acid-loaded poly lactic-co-glycolic acid nanoparticles: A strategy of treating breast cancer.
Dutta S; Chakraborty P; Basak S; Ghosh S; Ghosh N; Chatterjee S; Dewanjee S; Sil PC
Life Sci; 2022 Oct; 307():120876. PubMed ID: 35961595
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
[TBL] [Abstract][Full Text] [Related]
4. Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitors in triple-negative breast cancer cell line.
Byrne CE; Astete CE; Vaithiyanathan M; Melvin AT; Moradipour M; Rankin SE; Knutson BL; Sabliov CM; Martin EC
Nanomedicine (Lond); 2020 Apr; 15(10):981-1000. PubMed ID: 32238059
[No Abstract] [Full Text] [Related]
5. Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer.
Scully MA; Wilkins DE; Dang MN; Hoover EC; Aboeleneen SB; Day ES
Mol Pharm; 2023 Aug; 20(8):3895-3913. PubMed ID: 37459272
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer.
Dinakar YH; Rajana N; Kumari NU; Jain V; Mehra NK
AAPS PharmSciTech; 2023 Dec; 24(8):258. PubMed ID: 38097825
[TBL] [Abstract][Full Text] [Related]
7. IR820-loaded PLGA nanoparticles for photothermal therapy of triple-negative breast cancer.
Valcourt DM; Dang MN; Day ES
J Biomed Mater Res A; 2019 Aug; 107(8):1702-1712. PubMed ID: 30920169
[TBL] [Abstract][Full Text] [Related]
8. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
[TBL] [Abstract][Full Text] [Related]
9. Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy.
Bhargava-Shah A; Foygel K; Devulapally R; Paulmurugan R
Nanomedicine (Lond); 2016 Feb; 11(3):235-47. PubMed ID: 26787319
[TBL] [Abstract][Full Text] [Related]
10. Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancer.
Chaudhari D; Kuche K; Yadav V; Ghadi R; Date T; Bhargavi N; Jain S
Drug Deliv Transl Res; 2023 Apr; 13(4):1074-1087. PubMed ID: 36528709
[TBL] [Abstract][Full Text] [Related]
11. Delivery of novel coumarin-dihydropyrimidinone conjugates through mixed polymeric nanoparticles to potentiate therapeutic efficacy against triple-negative breast cancer.
Ghosh A; Upadhyay P; Sarker S; Das S; Bhattacharjee M; Bhattacharya S; Ahir M; Guria S; Gupta P; Chattopadhyay S; Ghosh S; Adhikari S; Adhikary A
Biomater Sci; 2021 Aug; 9(16):5665-5690. PubMed ID: 34259681
[TBL] [Abstract][Full Text] [Related]
12. Dual Functions of Riboflavin-functionalized Poly(lactic-co-glycolic acid) Nanoparticles for Enhanced Drug Delivery Efficiency and Photodynamic Therapy in Triple-negative Breast Cancer Cells.
Mekseriwattana W; Phungsom A; Sawasdee K; Wongwienkham P; Kuhakarn C; Chaiyen P; Katewongsa KP
Photochem Photobiol; 2021 Nov; 97(6):1548-1557. PubMed ID: 34109623
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy.
Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z
Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837
[TBL] [Abstract][Full Text] [Related]
14. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
[TBL] [Abstract][Full Text] [Related]
15. Coating of chitosan on poly D,L-lactic-co-glycolic acid thymoquinone nanoparticles enhances the anti-tumor activity in triple-negative breast cancer.
Gao J; Kumari A; Zeng XA; Chan S; Farooq MA; Alee M; Khan SH; Rahaman A; He S; Xin X; Mehmood T
Front Chem; 2023; 11():1044953. PubMed ID: 36846852
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Calcium Hydroxide-loaded Poly(Lactic-co-glycolic Acid) Biodegradable Nanoparticles in the
Chaiyosang P; Mahatnirunkul T; Leelapornpisid W
J Contemp Dent Pract; 2023 Jun; 24(6):351-356. PubMed ID: 37534500
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
Wang S; Zhang J; Wang Y; Chen M
Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
[TBL] [Abstract][Full Text] [Related]
18. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.
Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA
Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232
[TBL] [Abstract][Full Text] [Related]
19. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
[TBL] [Abstract][Full Text] [Related]
20. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells.
Sharma A; Hawthorne S; Jha SK; Jha NK; Kumar D; Girgis S; Goswami VK; Gupta G; Singh S; Dureja H; Chellappan DK; Dua K
Nanomedicine (Lond); 2021 Aug; 16(20):1763-1773. PubMed ID: 34296625
[No Abstract] [Full Text] [Related]
[Next] [New Search]